The ISoP PatEG-SIG for Promoting Patient Engagement in Pharmacovigilance: A Change of Paradigm is Needed Manal M. YounusMayada AlkhakanyMohamed A. Elhawary From the ISoP 25 May 2023 Pages: 619 - 623
Factors Associated with Underreporting of Adverse Drug Reactions by Health Care Professionals: A Systematic Review Update Patricia García-AbeijonCatarina CostaAdolfo Figueiras Systematic Review Open access 06 June 2023 Pages: 625 - 636
Safety and Effectiveness of Rasagiline in Chinese Patients with Parkinson’s Disease: A Prospective, Multicenter, Non-interventional Post-marketing Study Wen SuZhanhua LiangHaibo Chen Original Research Article Open access 17 May 2023 Pages: 637 - 646
Development and Application of an Active Pharmacovigilance Framework Based on Electronic Healthcare Records from Multiple Centers in Korea Seon ChoeSuhyun LeeJu Han Kim Original Research Article 27 May 2023 Pages: 647 - 660
Prenatal exposure to pregabalin, birth outcomes and neurodevelopment – a population-based cohort study in four Nordic countries Elena DudukinaSzimonetta Komjáthiné SzépligetiGunnar Toft Original Research Article Open access 26 April 2023 Pages: 661 - 675
Expert Consensus on the Nephrotoxic Potential of 195 Medications in the Non-intensive Care Setting: A Modified Delphi Method Britney A. StottlemyerKaleab Z. AbebeSandra L. Kane-Gill Original Research Article 24 May 2023 Pages: 677 - 687
Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Medicinal Products Containing Valproate: An Interrupted Time Series Study Shahab AbtahiRomin PajouheshniaOlaf Klungel Original Research Article Open access 09 June 2023 Pages: 689 - 702
Sustained Decline of Direct General Practitioner Reporting of Adverse Drug Reactions in Australia and Paucity in Details of Australian Reports in Safety Advisories Ian W. BoydJohn McEwen Original Research Article 02 June 2023 Pages: 703 - 710